Cells and Strains
| Catalog No: | CUBRC0011 |
| Description: | Infection of Rev-A3R5-GFP by HIV results in GFP expression in 2-5 days. Rev-A3R5-GFP is permissive t.. |
| Size: | One vial of 5 x 10⁶ cells. |
| Catalog No: | CUBRC0012 |
| Description: | Infection of Rev-A3R5-GFP/Luc by HIV results in GFP/Luc expression in 2-5 days. Rev-A3R5-GFP/Luc is .. |
| Size: | One vial of 5 x 10⁶ cells. |
| Catalog No: | CUBRC0022 |
| Description: | Infection of Rev-A3-GFP/Luc by HIV results in GFP/Luc expression in 2-5 days. Rev-A3-GFP/Luc is perm.. |
| Size: | One vial of 5 x 10⁶ cells. |
| Catalog No: | CUBRC0031 |
| Description: | Infection of Rev-CEM-GFP by HIV results in GFP expression in 2-5 days. Rev-CEM-GFP is permissive to .. |
| Size: | One vial of 5 x 10⁶ cells. |
| Catalog No: | CUBRC0032 |
| Description: | Infection of Rev-CEM-GFP/Luc by HIV results in GFP expression in 2-5 days. Rev-CEM-GFP/Luc is permis.. |
| Size: | One vial of 5 x 10⁶ cells. |
| Catalog No: | CUBRC0033 |
| Description: | Infection of Rev-CEM-Luc by HIV results in GFP expression in 2-5 days. Rev-CEM-Luc is permissive to .. |
| Size: | One vial of 5 x 10⁶ cells. |
| Catalog No: | CUBME0012 |
| Description: | ViroVision™ Infection Medium (patent pending) is a unique, HIV-specific infection enhancer that does.. |
| Applications: | Enhancing lenti- or retroviral transduction of target cells; Enhancing infection rates of other enveloped viruses; Facilitating recovery of infectious viruses from cell or tissue cultures; Facilitating anti-viral drug screening efficiency. |
| Catalog No: | CUBME0011 |
| Description: | ViroVision™ Infection Medium (patent pending) is a unique, HIV-specific infection enhancer that does.. |
| Applications: | Enhancing lenti- or retroviral transduction of target cells; Enhancing infection rates of other enveloped viruses; Facilitating recovery of infectious viruses from cell or tissue cultures; Facilitating anti-viral drug screening efficiency. |
| Catalog No: | CUBME0013 |
| Description: | ViroVision™ Infection Medium (patent pending) is a unique, HIV-specific infection enhancer that does.. |
| Applications: | Enhancing lenti- or retroviral transduction of target cells; Enhancing infection rates of other enveloped viruses; Facilitating recovery of infectious viruses from cell or tissue cultures; Facilitating anti-viral drug screening efficiency. |
Showing 1 to 9 of 9 (1 Pages)